B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:B. Braun Melsungen AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010856
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
B. Braun Melsungen AG (B. Braun) is a global health care company. It offers products and solutions for therapy fields and applications including acute dialysis, infusion therapy, apheresis, interventional vascular, diagnostics and treatment, cardio-thoracic surgery, laparoscopy, degenerative spine surgery, neurosurgery, diabetes, nutrition therapy, general open surgery, orthopedic joint replacement, hemodialysis, pain therapy, incontinence, stoma, infection prevention, and wound management. It has manufacturing facilities and R&D centers in the US, Europe and Asia. The company sells its products through a network of subsidiaries and associated companies in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.

B. Braun Melsungen AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
B. Braun Enters into Parntership with Royal Philip 11
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 12
Kinetic Concepts Enters into Co-Marketing Agreement with B. Braun Medical for Prontosan 13
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 14
Acquisition 15
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 15
B. Braun Medical Acquires Carenalis 16
B. Braun Avitum Acquires 51% Stake in Dialy Ser 17
B. Braun Melsungen Completes Acquisition Of Additional 3.02% Stake In Rhoen-Klinikum 18
B. Braun Singapore Completes Acquisition Of Majority Stake In Ahlcon Parenterals For US$48 Million 19
B. Braun Melsungen Acquires 5% Stake In Rhoen-Klinikum 21
B. Braun Melsungen Acquires Nutrichem diat+pharma From SSP 22
B. Braun Melsungen AG – Key Competitors 23
B. Braun Melsungen AG – Key Employees 24
B. Braun Melsungen AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 29
Recent Developments 31
Strategy And Business Planning 31
Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 31
Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 32
Financial Announcements 33
Mar 31, 2017: B. Braun continues its sales and earnings growth 33
Mar 23, 2016: B. Braun’s growth trend continues 35
Corporate Communications 37
Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 37
Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 38
Feb 22, 2017: Change in the B. Braun Management Board 39
Oct 05, 2016: B. Braun Supports The International Safety Center 40
Other Significant Developments 41
Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 41
Feb 15, 2017: B. Braun Medical to Present Comprehensive Parenteral Nutrition Program at ASPEN’s Clinical Nutrition Week 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
B. Braun Enters into Parntership with Royal Philip 11
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 12
Kinetic Concepts Enters into Co-Marketing Agreement with B. Braun Medical for Prontosan 13
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 14
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 15
B. Braun Medical Acquires Carenalis 16
B. Braun Avitum Acquires 51% Stake in Dialy Ser 17
B. Braun Melsungen Completes Acquisition Of Additional 3.02% Stake In Rhoen-Klinikum 18
B. Braun Singapore Completes Acquisition Of Majority Stake In Ahlcon Parenterals For US$48 Million 19
B. Braun Melsungen Acquires 5% Stake In Rhoen-Klinikum 21
B. Braun Melsungen Acquires Nutrichem diat+pharma From SSP 22
B. Braun Melsungen AG, Key Competitors 23
B. Braun Melsungen AG, Key Employees 24
B. Braun Melsungen AG, Other Locations 25
B. Braun Melsungen AG, Subsidiaries 25
B. Braun Melsungen AG, Joint Venture 29

★海外企業調査レポート[B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tokio Marine & Nichido Fire Insurance Co., Ltd.:企業のM&A・事業提携・投資動向
    Tokio Marine & Nichido Fire Insurance Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tokio Marine & Nichido Fire Insurance Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descript …
  • Laboratoires Pierre Fabre SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs …
  • Olea Medical SA:医療機器:M&Aディール及び事業提携情報
    Summary Olea Medical SA (Olea Medical), a subsidiary of Toshiba Medical Systems Corp, is a healthcare technology company that designs and markets medical imaging software products to healthcare industry. The company provides products such as advanced MR and CT perfusion imaging post-processing softw …
  • Hallador Energy Co (HNRG):企業の財務・戦略的SWOT分析
    Hallador Energy Co (HNRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pioneer Distilleries Limited:企業の戦略・SWOT・財務分析
    Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report Summary Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Northfork Electric Cooperative, Inc.:発電所・企業SWOT分析
    Northfork Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Xylem Inc.:企業の戦略・SWOT・財務情報
    Xylem Inc. - Strategy, SWOT and Corporate Finance Report Summary Xylem Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AB-Biotics SA (ABB):製薬・医療:M&Aディール及び事業提携情報
    Summary AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprieta …
  • Guizhou Space Appliance Co., Ltd.:企業の戦略・SWOT・財務情報
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Rehrig Pacific Company:企業の戦略的SWOT分析
    Rehrig Pacific Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NCC Group plc:企業の戦略・SWOT・財務分析
    NCC Group plc - Strategy, SWOT and Corporate Finance Report Summary NCC Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • EnServe Group Limited:企業のM&A・事業提携・投資動向
    EnServe Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnServe Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Vedanta Ltd:戦略・SWOT・企業財務分析
    Vedanta Ltd - Strategy, SWOT and Corporate Finance Report Summary Vedanta Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ResMed Inc. (RMD):医療機器:M&Aディール及び事業提携情報
    Summary ResMed Inc. (ResMed) develops, manufactures and distributes medical equipment for the diagnosis, treatment and management respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include air flow generato …
  • Medidata Solutions Inc (MDSO):医療機器:M&Aディール及び事業提携情報
    Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data and analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data ana …
  • Voith GmbH:企業の戦略的SWOT分析
    Voith GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sanquin Blood Supply Foundation:企業の戦略的SWOT分析
    Sanquin Blood Supply Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Nagacorp Ltd:企業の戦略・SWOT・財務情報
    Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report Summary Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • China Resources Land Limited:企業の戦略・SWOT・財務情報
    China Resources Land Limited - Strategy, SWOT and Corporate Finance Report Summary China Resources Land Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆